Sandler Laura Lee's Form 4 filing
Oruka Therapeutics, Inc. (ORKA) · filed Jan 2, 2026
- Accession no.
- 0000907654-26-000002
- Filed
- Jan 2, 2026
- Trade date
- Jan 2, 2026
- Filing delay
- Same day
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 1 derivative transaction. Open-market sales total $370.8K. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Sandler Laura LeeCIK 0002075401 | Officer (Chief Operating Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 2, 2026 | Common Stock | MOption exerciseAcquired | +5,000 | $7.80 | +$39,000 | 218,084 | Direct | |
| Jan 2, 2026 | Common Stock | SSaleDisposed | −8,748 | $28.17 | −$246,431.16 | 209,336 | Direct | |
| Jan 2, 2026 | Common Stock | SSaleDisposed | −3,144 | $29.08 | −$91,427.52 | 206,192 | Direct | |
| Jan 2, 2026 | Common Stock | SSaleDisposed | −1,108 | $29.75 | −$32,963 | 205,084 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 2, 2026 | Common Stock | MOption exerciseDisposed | −5,000 | $0.00 | $0 | 94,996 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.